Farmers Trust Co. Has $6.19 Million Stake in The Procter & Gamble Company (NYSE:PG)

Farmers Trust Co. cut its position in shares of The Procter & Gamble Company (NYSE:PG) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 36,899 shares of the company’s stock after selling 76 shares during the quarter. Procter & Gamble accounts for about 1.2% of Farmers Trust Co.’s portfolio, making the stock its 26th biggest holding. Farmers Trust Co.’s holdings in Procter & Gamble were worth $6,186,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of PG. InvesTrust bought a new position in shares of Procter & Gamble in the 4th quarter valued at about $6,821,000. Fulton Bank N.A. increased its position in shares of Procter & Gamble by 1.3% during the 4th quarter. Fulton Bank N.A. now owns 27,630 shares of the company’s stock worth $4,632,000 after purchasing an additional 366 shares during the last quarter. Park National Corp OH raised its stake in shares of Procter & Gamble by 7.3% during the 4th quarter. Park National Corp OH now owns 260,399 shares of the company’s stock worth $43,656,000 after purchasing an additional 17,720 shares in the last quarter. Innova Wealth Partners acquired a new stake in shares of Procter & Gamble in the 4th quarter valued at approximately $731,000. Finally, Legend Financial Advisors Inc. grew its stake in shares of Procter & Gamble by 476.2% in the fourth quarter. Legend Financial Advisors Inc. now owns 582 shares of the company’s stock valued at $98,000 after buying an additional 481 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. DA Davidson reiterated a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research note on Friday, December 27th. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a research note on Monday, September 30th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Finally, Wells Fargo & Company decreased their target price on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a report on Tuesday. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $179.75.

Insider Buying and Selling

In other news, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This trade represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock valued at $13,317,460 over the last quarter. 0.18% of the stock is owned by company insiders.

Procter & Gamble Price Performance

Shares of NYSE PG traded up $0.78 during midday trading on Wednesday, reaching $162.08. The company’s stock had a trading volume of 2,823,317 shares, compared to its average volume of 6,081,301. The company has a market cap of $381.71 billion, a P/E ratio of 27.94, a P/E/G ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a fifty-two week low of $146.28 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The business’s 50 day moving average price is $169.92 and its two-hundred day moving average price is $169.75.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. During the same period in the previous year, the firm earned $1.83 EPS. The company’s quarterly revenue was down .6% compared to the same quarter last year. On average, analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.